Spyglass Pharma, Inc.
Clinical trials sponsored by Spyglass Pharma, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Glaucoma implant could replace daily eye drops Results expected Feb 2027 (estimated)
-
Glaucoma patients may soon ditch eye drops after cataract surgery
Disease control Recruiting nowThis phase 3 trial tests a bimatoprost implant placed inside the eye during cataract surgery to lower eye pressure in people with glaucoma or high eye pressure. About 400 participants will receive either the implant with a special lens or standard eye drops. The goal is to see if…
Phase 3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Glaucoma patients may soon ditch eye drops after cataract surgery
Disease control Recruiting nowThis study tests a bimatoprost implant placed inside the eye during cataract surgery to lower eye pressure in people with glaucoma or high eye pressure. About 400 participants will receive either the implant plus a special lens or standard eye drops. The goal is to see if the imp…
Phase 3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC